Huan Zhang

TL;DR: Recent developments and innovations in preclinical studies and clinical trials based on using CPP for improved delivery, which have revealed that CPPs or CPP-based delivery systems present outstanding diagnostic therapeutic delivery potential.

TL;DR: FA-NPs-CTX have great potential in CTX delivery, and this formulation is a promising candidate for the treatment of cancers with high FR levels.

TL;DR: In this paper, the authors developed an efficient anti-glioma drug with targeting and which was able to cross the BBB, cell-penetrating peptides (R8) and transferrin co-modified doxorubicin (DOX)-loaded liposomes (Tf-LPs) were prepared.

TL;DR: FA-PEG-NPs-CTX particles prepared using microfluidic technology showed high efficient and targeted drug delivery and may have a considerable driving effect on the clinical application of targeting albumin NPs.

TL;DR: TP 5-NPs showed great promise as an anticancer therapeutic agent based on its ability to inhibit tumor cell growth and exhibited high potency, according to the optimum conditions obtained by adjusting the temperature and concentration of TP 5.